Expand AUTL Menu
AUTL MENU

AUTL Stock Summary and Trading Ideas (Autolus Therapeutics PLC - American Depositary Shares | NASDAQ:AUTL)

Charts for Today's Stock Price and Implied Volatility in Autolus Therapeutics PLC - American Depositary Shares

4-Sep-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for AUTL by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Autolus Therapeutics PLC - American Depositary Shares (AUTL) Frequently Asked Questions

What does Autolus Therapeutics PLC - American Depositary Shares do?

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

What symbol and exchange does Autolus Therapeutics PLC - American Depositary Shares shares trade?

Autolus Therapeutics PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AUTL.

What is Autolus Therapeutics PLC - American Depositary Shares stock price doing today?

As of September 4, 2026, AUTL stock price declined to $2.24 with 1,797,165 million shares trading.

What is Autolus Therapeutics PLC - American Depositary Shares's Beta?

AUTL has a beta of 2.84, meaning it tends to be more sensitive to market movements. AUTL has a correlation of 0.21 to the broad based SPY ETF.

How much is Autolus Therapeutics PLC - American Depositary Shares worth?

AUTL has a market cap of $585.04 million. This is considered a Small Cap stock.

How much money does Autolus Therapeutics PLC - American Depositary Shares make?

Last quarter Autolus Therapeutics PLC - American Depositary Shares reported $46 million in Revenue and -$.15 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.04.

What is the highest and lowest price Autolus Therapeutics PLC - American Depositary Shares traded in the last 3 year period?

In the last 3 years, AUTL traded as high as $7.45 and as low as $1.11.

What are the top ETFs holding Autolus Therapeutics PLC - American Depositary Shares?

The top ETF exchange traded funds that AUTL belongs to (by Net Assets): IBB, CANC, GWX, QQQS, APIE.

Is Autolus Therapeutics PLC - American Depositary Shares (AUTL) a good investment?

AUTL has outperformed the market in the last year with a return of +54.5%, while the SPY ETF gained +19.8%. In the last 3 month period, AUTL beat the market returning +34.9%, while SPY returned +2.0%. However, in the most recent 2 weeks AUTL has underperformed the stock market by returning -7.1%, while SPY returned +0.6%.

What are the support and resistance levels for Autolus Therapeutics PLC - American Depositary Shares (AUTL)?

AUTL support price is $2.20 and resistance is $2.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AUTL shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes